Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: Role of ubiquitin-proteasome activity

Hypertension

Volumn 49, Issue 4, 2007, Pages 784-791

  Marfella, Raffaele ^a,d   Siniscalchi, Mario ^a   Portoghese, Michele ^b   Di Filippo, Clara ^a   Ferraraccio, Franca ^a   Schiattarella, Concetta ^a   Crescenzi, Basilio ^c   Sangiuolo, Paolo ^c   Ferraro, Giuseppe ^a   Siciliano, Silvio ^c   Cinone, Francesca ^a   Mazzarella, Gennaro ^a   Martis, Simone ^a   Verza, Mario ^a   Coppola, Ludovico ^a   Rossi, Francesco ^a,b   D'Amico, Michele ^b   Paolisso, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Sassari Hospital   (Italy)

^c Hospital V Monaldi   (Italy)

^d NONE   (Italy)

Author keywords

Atherosclerotic plaque; Inflammation; Morning blood pressure; Ubiquitin proteasome activity

Indexed keywords

3 NITROTYROSINE; COLLAGEN; GELATINASE B; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; 3-NITROTYROSINE; DRUG DERIVATIVE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BRAIN ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; IN VITRO STUDY; INFLAMMATION; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; UPREGULATION;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CAROTID ARTERY DISEASES; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; INFLAMMATION; INTRACRANIAL ARTERIOSCLEROSIS; NF-KAPPA B; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; TYROSINE; UBIQUITIN; UP-REGULATION;

EID: 34047199319     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000259739.64834.d4     Document Type: Article

References (25)

1. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, and the MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313:1315-1322.
2. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983;53:96-104.
3. Muller JE. Circadian variation in cardiovascular events. Am J Hypertens. 1999;12:35S-42S.
4. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in BP as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. A prospective study. Circulation. 2003;107:1401-1406.
5. Marfella R, Siniscalchi M, Nappo F, Gualdiero P, Esposito K, Sasso FC, Cacciapuoti F, Di Filippo C, Rossi F, D'Amico M, Giugliano D. Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients. Am J Hypertens. 2005;18:308-318.
6. Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovasc Res. 2004;61:11-21.
7. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 1994;78:773-785.
8. Marfella R, D'Amico M, Esposito K, Baldi A, Di Filippo C, Siniscalchi M, Sasso FC, Portoghese M, Cirillo F, Cacciapuoti F, Carbonara O, Crescenzi B, Baldi F, Ceriello A, Nicoletti GF, D'Andrea F, Verza M, Coppola L, Rossi F, Giugliano D. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Diabetes. 2006;55:622-632.
9. Marfella R, D'Amico M, Di Filippo C, Baldi A, Siniscalchi M, Sasso FC, Portoghese M, Carbonara O, Crescenzi B, Sangiulo P, Nicoletti GF, Rossiello R, Verza M, Rossi F, Coppola L, Paolisso G. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. J Am Coll Cardiol. 2006;47:2118-2120.
10. Kikuchi J, Furukawa Y, Kubo N, Tokura A, Hayashi N, Nakamura M, Matsuda M, Sakurabayashi I. Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis. Arteriosclerosis Thrombosis Vascular Biology. 2000;20:128-134.
11. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem. 1996;271:29223-29230.
12. Young B, Moore WS, Robertson JT, Toole JF, Ernst CB, Cohen SN, Broderick JP, Dempsey RJ, Hosking JD. An analysis of perioperative surgical mortality and morbility in the Asymptomatic Carotid Atherosclerosis Study. Stroke. 1996;27:2216-2224.
13. Marfella R, Gualdiero P, Siniscalchi M, Carusone C, Verza M, Marzano S, Esposito K, Giugliano D. Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension. 2003;41:237-243.
14. Ohlsson BG, Englund MCO, Karlsson ALK, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages. J Clin Invest. 1996;98:78-89.
15. de Vries HE, Buchner B, van Berkel TJ, Kuiper J. Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1999;19:638-645.
16. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 1994;10:405-455.
17. Herrmann J, Gulati R, Napoli C, Woodrum JE, Lerman LO, Rodriguez-Porcel M, Sica V, Simari RD, Ciechanover A, Lerman A. Oxidative stress-related increase in ubiquitination in early coronary atherosclerosis. FASEB J. 2003;17:1730-1732.
18. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86:515-581.
19. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
20. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation. 2004;109:2357-2362.
21. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med. 1999;4:223-230.
22. Versari D, Herrmann J, Gossl M, Mannheim D, Sattler K, Meyer FB, Lerman LO, Lerman A. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:2132-2139.
23. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
24. Kario K. Morning surge and variability in blood pressure: a new therapeutic target? Hypertension. 2005;45:485-486.
25. Kaneda R, Kario K, Hoshide S, Umeda Y, Hoshide Y, Shimada K. Morning blood pressure hyperreactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling population. Am J Hypertens. 2005;18:1528-1533.